Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
Open Access
- 1 August 1993
- journal article
- case report
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 56 (8) , 859-864
- https://doi.org/10.1136/jnnp.56.8.859
Abstract
Reduction in the regional cerebral metabolic rate for glucose (rCMRglc) in the parietal and temporal regions has been shown in Alzheimer's disease (AD). The specificity of these findings for this disease state is uncertain. We repeatedly measured rCMRglc with positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose in the resting state in a 68 year old man with slowly progressive dementia who, during life, was initially diagnosed as having dementia of the Alzheimer type, then Parkinson disease with dementia, but was found to have only Parkinson's disease at necropsy. Metabolic ratios (rCMRglc/mean grey CMRglc) were significantly (p < 0.05) reduced in parietal and temporal regions, as well as in the prefrontal and premotor areas. This pattern was similar in regional distribution and magnitude of the defect to that seen in patients with probable AD. These results suggest that reductions of glucose metabolism in association neocortex in AD are not specific to the disease process, but may be related to the dementia state.Keywords
This publication has 27 references indexed in Scilit:
- Integrated phylogeny of the primate brain, with special reference to humans and their diseasesBrain Research Reviews, 1990
- TIME COURSE OF EFFECTS OF UNILATERAL LESIONS OF THE NUCLEUS BASALIS OF MEYNERT ON GLUCOSE UTILIZATION BY THE CEREBRAL CORTEXBrain, 1989
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986
- Bitemporal Hypometabolism in Creutzfeldt-Jakob Disease Measured by Positron Emission Tomography with [18F]-2-FluorodeoxyglucoseJournal of Computer Assisted Tomography, 1984
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose methodAnnals of Neurology, 1984
- CORTICAL CHOLINERGIC DEFICIT IN MENTALLY IMPAIRED PARKINSONIAN PATIENTSThe Lancet, 1983
- PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASENeuropathology and Applied Neurobiology, 1983
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- “Mini-mental state”Journal of Psychiatric Research, 1975